{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:31:23Z","timestamp":1740126683690,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12253-019-00624-1","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:07:25Z","timestamp":1551312445000},"page":"783-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Haphazard Pattern in Grade-3 Endometrioid Carcinoma Is Associated with Poor Prognosis and Tumor Lymphocyte Infiltration"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-0926","authenticated-orcid":false,"given":"Morikazu","family":"Miyamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Soyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"Suppl 2","key":"624_CR1","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.ijgo.2015.06.010.","volume":"131","author":"J Prat","year":"2015","unstructured":"Prat J (2015) Pathology of cancers of the female genital tract. Int J Gynaecol Obstet 131(Suppl 2):S132\u2013S145. \nhttps:\/\/doi.org\/10.1016\/j.ijgo.2015.06.010.","journal-title":"Int J Gynaecol Obstet"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67\u201373. \nhttps:\/\/doi.org\/10.1038\/nature12113","journal-title":"Nature"},{"key":"624_CR3","unstructured":"Clinical Practice Guideline in Oncology. National Comprehensive Cancer Network. \nHttp:\/\/www.nccn.org\/professionals\/physician-gls\/PDF\/uterine.pdf\n\n. Accessed 04 Jan 2019"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E (2016) Endometrial cancer. Lancet. 387:1094\u20131108. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(15)00130-0\n\n Epub 2015 Sep 6","journal-title":"Lancet."},{"key":"624_CR5","first-page":"126","volume-title":"WHO classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014) WHO classification of tumours of female reproductive organs. International Agency for Research on Cancer, Lyon, pp 126\u2013133"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","volume":"116","author":"SN Lewin","year":"2010","unstructured":"Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X, Wright JD (2010) Comparative performance of the 2009 international federation of gynecology and obstetrics' staging system for uterine corpus cancer. Obstet Gynecol 116:1141\u20131149. \nhttps:\/\/doi.org\/10.1097\/AOG.0b013e3181f39849","journal-title":"Obstet Gynecol"},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3892\/ol.2016.4918","volume":"12","author":"J Wang","year":"2016","unstructured":"Wang J, Jia N, Li Q, Wang C, Tao X, Hua K, Feng W (2016) Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma. Oncol Lett 12:2860\u20132867. \nhttps:\/\/doi.org\/10.3892\/ol.2016.4918","journal-title":"Oncol Lett"},{"key":"624_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ygyno.2009.10.043","volume":"116","author":"N Rasool","year":"2010","unstructured":"Rasool N, Fader AN, Seamon L, Neubauer NL, Shahin FA, Alexander HA, Moore K, Moxley K, Secord AA, Kunos C, Rose PG, O'Malley DM (2010) Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol 116:10\u201314. \nhttps:\/\/doi.org\/10.1016\/j.ygyno.2009.10.043\n\n Epub 2009 Oct 28","journal-title":"Gynecol Oncol"},{"key":"624_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000493010","volume":"3","author":"M Miyamoto","year":"2018","unstructured":"Miyamoto M, Takano M, Tsuda H, Matuura H, Aoyama T, Soyama H, Kato K, Iwahashi H, Ishibashi H, Yoshikawa T, Suzuki A, Hirata J, Furuya K (2018) Zone formation of lymphocyte infiltration at invasive front as a biomarker of prognosis in endometrial carcinomas. Oncology 3:1\u20138. \nhttps:\/\/doi.org\/10.1159\/000493010","journal-title":"Oncology"},{"key":"624_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ygyno.2013.11.015","volume":"132","author":"JB McIntyre","year":"2014","unstructured":"McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, K\u00f6bel M (2014) PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma. Gynecol Oncol 132:188\u2013193. \nhttps:\/\/doi.org\/10.1016\/j.ygyno.2013.11.015","journal-title":"Gynecol Oncol"},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ygyno.2014.05.006.","volume":"132","author":"B Meng","year":"2014","unstructured":"Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, K\u00f6bel M (2014) POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Gynecol Oncol 132:188\u2013193. \nhttps:\/\/doi.org\/10.1016\/j.ygyno.2014.05.006.","journal-title":"Gynecol Oncol"},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1440-1827.2003.01509.x","volume":"53","author":"C Suzuki","year":"2003","unstructured":"Suzuki C, Matsumoto T, Sonoue H, Arakawa A, Furugen Y, Kinoshita K (2003) Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium. Pathol Int 53:495\u2013500","journal-title":"Pathol Int"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00000478-199901000-00007","volume":"23","author":"TA Longacre","year":"1999","unstructured":"Longacre TA, Hendrickson MR (1999) Diffusely infiltrative endometrial adenocarcinoma. An adenoma malignum pattern of myoinvasion. Am J Surg Pathol 23:69\u201378","journal-title":"Am J Surg Pathol"},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","volume":"101","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101:293\u2013299. \nhttps:\/\/doi.org\/10.1111\/j.1349-7006.2009.01419.x","journal-title":"Cancer Sci"},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12094-012-0866-3","volume":"14","author":"E Colas","year":"2012","unstructured":"Colas E, Pedrola N, Devis L, Ertekin T, Campoy I, Mart\u00ednez E, Llaurad\u00f3 M, Rigau M, Olivan M, Garcia M, Cabrera S, Gil-Moreno A, Xercavins J, Castellvi J, Garcia A, Ramon y Cajal S, Moreno-Bueno G, Dolcet X, Alameda F, Palacios J, Prat J, Doll A, Matias-Guiu X, Abal M, Reventos J (2012) The EMT signaling pathways in endometrial carcinoma. Clin Transl Oncol 14:715\u2013720. \nhttps:\/\/doi.org\/10.1007\/s12094-012-0866-3","journal-title":"Clin Transl Oncol"},{"issue":"Suppl","key":"624_CR16","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1309\/64CW-WKGK-49EF-BYD1","volume":"115","author":"JH Eichhorn","year":"2001","unstructured":"Eichhorn JH, Young RH (2001) Neuroendocrine tumors of the genital tract. Am J Clin Pathol 115(Suppl):S94\u2013S112. \nhttps:\/\/doi.org\/10.1309\/64CW-WKGK-49EF-BYD1","journal-title":"Am J Clin Pathol"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00004347-199501000-00005","volume":"14","author":"KH van Hoeven","year":"1995","unstructured":"van Hoeven KH, Hudock JA, Woodruff JM, Suhrland MJ (1995) Small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol 14:21\u201329","journal-title":"Int J Gynecol Pathol"},{"key":"624_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/0046-8177(95)90013-6","volume":"26","author":"H Niikura","year":"1995","unstructured":"Niikura H, Sasano H, Matsunaga G, Watanabe K, Ito K, Sato S, Yajima A (1995) Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. Hum Pathol 26:892\u2013896","journal-title":"Hum Pathol"},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ijc.21415","volume":"118","author":"IM Stefansson","year":"2006","unstructured":"Stefansson IM, Salvesen HB, Akslen LA (2006) Loss of p63 and cytokeratin 5\/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. Int J Cancer 118:1227\u20131233. \nhttps:\/\/doi.org\/10.1002\/ijc.21415","journal-title":"Int J Cancer"},{"key":"624_CR20","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1158\/1078-0432.CCR-16-1820","volume":"22","author":"JM Piulats","year":"2016","unstructured":"Piulats JM, Matias-Guiu X (2016) Immunotherapy in endometrial Cancer: in the Nick of time. Clin Cancer Res 22:5623\u20135625. \nhttps:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1820","journal-title":"Clin Cancer Res"},{"key":"624_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/PAS.0b013e318247b7bb","volume":"36","author":"T Alvarez","year":"2012","unstructured":"Alvarez T, Miller E, Duska L, Oliva E (2012) Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma? Am J Surg Pathol 36:753\u2013761. \nhttps:\/\/doi.org\/10.1097\/PAS.0b013e318247b7bb","journal-title":"Am J Surg Pathol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00624-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00624-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T13:11:45Z","timestamp":1590066705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00624-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00624-1","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"type":"print","value":"1219-4956"},{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"3 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. This study was approved by the Ethics Committee of the National Defense Medical College, Tokorozawa, Japan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"Because our study was retrospective study, informed consent was not obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}